Inventiva IVA 深 滬
已收盤 08-07 16:00:00 美东时间
4.80
+0.140
+3.00%
華盛通- 最 高4.94
- 今 開4.90
- 成交量 57.91万股
- 最 低 4.80
- 昨 收 4.66
- 總市值 11.34亿
- 52周最高 7.9825
- 市盈率 靜 --
- 換手率 0.25%
- 52周最低 3.35
- 委 比 21.47%
- 總股本 2.36亿
- 歷史最高 19.064
- 量 比 0.65
- 振 幅 3.00%
- 歷史最低 1.53
- 每 手 1
- 風險率 0.91%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Inventiva S.A reports Preliminary 1H results
Inventiva S.A press release (IVA): 1H Net cash used in operating activities amounted to (€48.7) million for the first half of 2026, compared to (€53.7) million for the same period in 2025. As at June...
07-30 04:52
Cantor Fitzgerald Initiates Coverage On Inventiva with Overweight Rating
Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on Inventiva (NASDAQ:IVA) with a Overweight rating.
07-17 19:58
Kura Sushi Posts Weak Q3 Sales, Joins FuelCell Energy And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling more than 500 points on Wednesday. Shares of Kura Sushi USA, Inc. (NASDAQ:KRUS) fell sharply in pre-market trading after the company reported worse-than-expected third-quarter sales results. Kura Sushi reported quarterly earnin...
07-08 20:04
美股牛股 | 制药企业CRNX股价狂飙近99%！获福泰制药百亿美元高溢价收购；罕见病药物研究公司AGIO涨18%
制药企业CRNX股价狂飙近99%！获福泰制药百亿美元高溢价收购；罕见病药物研究公司AGIO涨18%，核心产品新药申请获FDA受理；基因治疗药物研发企业NGNE涨13%，公司成功完成新一轮融资>>
07-08 19:19
Super Micro Computer, Summit Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were lower this morning, with the Nasdaq futures falling around 1% on Wednesday. Shares of Super Micro Computer Inc (NASDAQ:SMCI) fell sharply in pre-market trading after the company announced a proposed offering to fund AI orders. Super Micro announced a series of offerings expec...
06-10 20:03
Inventiva Halts Paris Trading Ahead of Planned Financing Announcement, Shares Expected to Resume Trading Later Tuesday
Inventiva (NASDAQ:IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis
06-02 16:36
